The Patent Finder
US

Foamable Compositions, Breakable Foams And Their Uses

US 10,092,588 Lapsed on the fee record
OverviewFamilyAssignmentsSources & methods
Collateral for a security interest recorded Dec 28, 2023 (SWK Funding LLC).

Lapsed Oct 9, 2022 on the fee record · High confidence

First maintenance fee unpaid; grace period ended.

Filed Jan 9, 2017 as application 15/401,743 · Granted Oct 9, 2018
Base term, 20 years from filing, plus 16 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
Lapsed Oct 9, 2022
2010 2030
Clock starts
Jul 29, 2010
No longer in force
Oct 9, 2022
Granted
Oct 9, 2018
Term would have run to
Jul 29, 2030
base term after the term ends Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
16
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 9,167,813, US 9,572,775.
0 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
5
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

Its term would have run to Jul 29, 2030: its 20-year base term plus 16 days of term adjustment for prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Jul 29, 2010, when application PCT/IB2010/002241, the earliest non-provisional in its chain, was filed (this one was filed Jan 9, 2017)Jul 29, 2030High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+16 days, USPTO patent term adjustment recordAug 14, 2030High confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 9,167,813, US 9,572,775)capped to Jul 29, 2030High confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events0 of 2 maintenance fees paidlapsed Oct 9, 2022High confidence
Computed term endThe steps above, in orderOct 9, 2022High confidence

Partial family

Application PCT/IB2010/002241PCT application
no patent term
no patent term
US 9,167,813In force
Jul 2030
Jul 2030
US 9,572,775In force
Jul 2030
Jul 2030
US 10,092,588this patent
Oct 2022
Oct 2022
US 11,219,631In force
Jul 2030
Jul 2030
Partial: 1 of the 5 has no file history here, so its row comes from the patent's own record or names the application alone. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Apr 20, 2017
Reel 42073, frame 265
Tamarkin, Dov; Ziv, Enbal; Hazot, Yohan; Schuz, DavidFoamix Ltd.Assignment of Assignor's Interest
Aug 14, 2018
Reel 46780, frame 445
Foamix Ltd.Foamix Pharmaceuticals Ltd.Change of Name
Jul 30, 2019
Reel 49912, frame 45
Foamix Pharmaceuticals Ltd.Perceptive Credit Holdings II, LPPatent Security Agreement
Nov 4, 2020
Reel 54306, frame 387
Foamix Pharmaceuticals Ltd.Vyne Pharmaceuticals Ltd.Change of Name
Feb 4, 2021
Reel 55215, frame 298
Vyne Pharmaceuticals Ltd.Vyne Therapeutics Inc.Assignment of Assignor's Interest
Feb 17, 2021
Reel 55326, frame 9
Vyne Therapeutics Inc.Perceptive Credit Holdings II, LPPatent Security Agreement
Sep 20, 2021
Reel 57544, frame 138
Perceptive Credit Holdings II, LPVyne Pharmaceuticals Ltd. (F/K/A Foamix Pharmaceuticals Ltd.)Release of Security Interest
Sep 20, 2021
Reel 57544, frame 708
Perceptive Credit Holdings II, LPVyne Therapeutics Inc. (F/K/A Menlo Therapeutics Inc. and Successor-in-Interest to Vyne Pharmaceuticals Ltd., F/K/A Foamix Pharmaceuticals Ltd.)Release of Security Interest
Dec 22, 2021
Reel 58463, frame 167
Vyne Therapeutics Inc.Vyne Pharmaceuticals Inc.Assignment of Assignor's Interest
Feb 1, 2022
Reel 58925, frame 568
Vyne Therapeutics Inc.; Vyne Pharmaceuticals Inc.Journey Medical CorporationAssignment of Assignor's Interest
Dec 28, 2023
Reel 66157, frame 79
Journey Medical Corporation; JG Pharma, Inc.SWK Funding LLCSecurity Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited